16 July 2025NewsPatentsMichael Shuster, Goodwin Law | Erica LoRe, Invivyd | Guy Birkenmeier, New England Biolabs

WATCH: Patents s101—how to overcome the current complexity of patent eligibility in the US

LSPN experts from Goodwin Law, Invivyd, and New England Biolabs discuss the challenges of patent eligibility under 35 U.S.C. § 101 in life sciences innovation. The session explores strategies to address obstacles arising from recent court decisions and USPTO guidelines.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

Weil continues IP expansion as another litigator jumps from rival firm

WIPR Rankings reveals the go-to firms and attorneys for China patent work

Fed Circ won’t bite on first IPR-policy challenges

New AIPLA president calls for greater certainty in US patent law

Squires plays rare reexamination of Pokémon gaming patent

WATCH: AI for patent drafting & prosecution—reshaping IP workflows

AI is an upstart teen: Meta, Adobe counsel on where the tech is at

Squires: ‘Inherited patent backlog was an absolute dumpster fire’

WATCH: Patents s101—how to overcome the current complexity of patent eligibility in the US

Editor's picks

Editor's picks

More articles